The impact of neratinib with or without anti-diarrheal prophylaxis on health-related quality of life in HER2+early-stage breast cancer: Analyses from the ExteNET and CONTROL trials

CANCER RESEARCH(2019)

Cited 1|Views300
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined